Brief: EQL Pharma Q1 EBIT SEK 15.2 Million
08/08/2024 06:01
Aug 08 (Reuters) - EQL Pharma Q1 EBIT margin 18%. * Q1 revenue SEK 82.8 million * Q1 adjusted free cash flow SEK -19.8 million
EQL — EQL Pharma AB News Story
0.000.00%
Last trade - 00:00- SEK670.32m
- SEK1.07bn
- SEK432.66m